Illumina (ILMN) Posts Quarterly Earnings Results, Beats Estimates By $0.05 EPS
Illumina (NASDAQ:ILMN) posted its quarterly earnings results on Monday. The company reported $0.45 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.40 by $0.05, AnalystRatingsNetwork reports. The company had revenue of $357.00 million for the quarter, compared to the consensus estimate of $343.42 million.
Shares of Illumina (NASDAQ:ILMN) traded up 0.41% during mid-day trading on Monday, hitting $81.76. The stock had a trading volume of 1,998,839 shares. Illumina has a 52 week low of $44.78 and a 52 week high of $85.81. The stock has a 50-day moving average of $80.70 and a 200-day moving average of $73.10. The company has a market cap of $10.230 billion and a price-to-earnings ratio of 95.80.
In other Illumina news, Director David R. Walt sold 5,000 shares of Illumina stock in a transaction that occurred on Wednesday, October 16th. The shares were sold at an average price of $82.59, for a total value of $412,950.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.
Several analysts have recently commented on the stock. Analysts at Wedbush raised their price target on shares of Illumina from $60.00 to $65.00 in a research note to investors on Tuesday, October 15th. They now have a “neutral” rating on the stock. On a related note, analysts at Bank of America Corp. reiterated a “buy” rating on shares of Illumina in a research note to investors on Friday, September 27th. They now have a $90.00 price target on the stock. Finally, analysts at Goldman Sachs Group Inc. raised their price target on shares of Illumina from $73.00 to $74.00 in a research note to investors on Friday, September 27th. They now have a “neutral” rating on the stock. One research analyst has rated the stock with a sell rating, eight have given a hold rating and eight have assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average price target of $74.96.
Illumina, Inc (NASDAQ:ILMN) is a developer and manufacturer of life science tools and integrated systems for the analysis of genetic variation and function.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.